betaloc

基本解释

The control group was additionally treated with Betaloc.
对照组显效率为28%25,有效率为24%25,总有效率为52%25。
Spironolactone with Betaloc is effective and safety mean for treating chronic heart failure induced by CHD and HHD.
小剂量螺内酯联用倍他乐克配合常规治疗用于冠心病及高血压性心脏病慢性心力衰竭的疗效显著、安全、价廉。
Objective To observe the effect of captopril and betaloc on chronic congestive heart failure(CHF).
目的联用卡托普利及倍他乐克治疗慢性充血性心力衰竭(CHF)观察疗效。
Objective:To explore the efficacy of betaloc in treating dilated cardiomyopathy(DCM) .
目的:观察倍他乐克对扩张型心肌病(DCM)的疗效。
Conelusion The intial dosage of captopril and betaloc and significient effect in treating heart failure.
结论血管紧张素转换酶抑制剂和美托洛尔从小剂量开始,逐渐达靶剂量维持用药对治疗心力衰竭疗效显著。